Contineum Therapeutics
CTNM
$15.50
Share price
3.61%
Change (1 day)
N/A
Change (1 year)
Categories
Contineum Therapeutics (CTNM) - Cash on Hand
Cash on Hand as of December 2023 : $0.12 B
According to Contineum Therapeutics's latest financial reports the company has $0.12 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Contineum Therapeutics - Cash on Hand chart (from 2022 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.12 B | 165.01% |
| 2022-12-31 | $47.23 M | -31.54% |
| 2021-12-31 | $69 M |